Literature DB >> 22234336

Insulin-induced generation of reactive oxygen species and uncoupling of nitric oxide synthase underlie the cerebrovascular insulin resistance in obese rats.

Prasad V G Katakam1, James A Snipes, Mesia M Steed, David W Busija.   

Abstract

Hyperinsulinemia accompanying insulin resistance (IR) is an independent risk factor for stroke. The objective is to examine the cerebrovascular actions of insulin in Zucker obese (ZO) rats with IR and Zucker lean (ZL) control rats. Diameter measurements of cerebral arteries showed diminished insulin-induced vasodilation in ZO compared with ZL. Endothelial denudation revealed vasoconstriction to insulin that was greater in ZO compared with ZL. Nonspecific inhibition of nitric oxide synthase (NOS) paradoxically improved vasodilation in ZO. Scavenging of reactive oxygen species (ROS), supplementation of tetrahydrobiopterin (BH(4)) precursor, and inhibition of neuronal NOS or NADPH oxidase or cyclooxygenase (COX) improved insulin-induced vasodilation in ZO. Immunoblot experiments revealed that insulin-induced phosphorylation of Akt, endothelial NOS, and expression of GTP cyclohydrolase-I (GTP-CH) were diminished, but phosphorylation of PKC and ERK was enhanced in ZO arteries. Fluorescence studies showed increased ROS in ZO arteries in response to insulin that was sensitive to NOS inhibition and BH(4) supplementation. Thus, a vicious cycle of abnormal insulin-induced ROS generation instigating NOS uncoupling leading to further ROS production underlies the cerebrovascular IR in ZO rats. In addition, decreased bioavailability and impaired synthesis of BH(4) by GTP-CH induced by insulin promoted NOS uncoupling.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22234336      PMCID: PMC3345912          DOI: 10.1038/jcbfm.2011.181

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  38 in total

1.  Impaired endothelin-induced vasoconstriction in coronary arteries of Zucker obese rats is associated with uncoupling of [Ca2+]i signaling.

Authors:  Prasad V G Katakam; James A Snipes; Christina D Tulbert; Keita Mayanagi; Allison W Miller; David W Busija
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-12-01       Impact factor: 3.619

2.  Impaired insulin-induced vasodilation in small coronary arteries of Zucker obese rats is mediated by reactive oxygen species.

Authors:  Prasad V G Katakam; Christina D Tulbert; James A Snipes; Benedek Erdös; Allison W Miller; David W Busija
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-02       Impact factor: 4.733

3.  Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke.

Authors:  K Matsumoto; S Miyake; M Yano; Y Ueki; A Miyazaki; K Hirao; Y Tominaga
Journal:  Diabetes Care       Date:  1999-07       Impact factor: 19.112

4.  Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H oxidase-dependent superoxide production.

Authors:  Benedek Erdös; James A Snipes; Christina D Tulbert; Prasad Katakam; Allison W Miller; David W Busija
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-11-11       Impact factor: 4.733

Review 5.  Impact of obesity and insulin resistance on vasomotor tone: nitric oxide and beyond.

Authors:  David W Stepp
Journal:  Clin Exp Pharmacol Physiol       Date:  2006 May-Jun       Impact factor: 2.557

6.  Type 2 diabetic mice have increased arteriolar tone and blood pressure: enhanced release of COX-2-derived constrictor prostaglandins.

Authors:  Zsolt Bagi; Nora Erdei; Attila Toth; Wei Li; Thomas H Hintze; Akos Koller; Gabor Kaley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-06-09       Impact factor: 8.311

7.  Oxidant stress and constrictor reactivity impair cerebral artery dilation in obese Zucker rats.

Authors:  Shane A Phillips; Francis A Sylvester; Jefferson C Frisbee
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-10-28       Impact factor: 3.619

8.  Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavenger.

Authors:  C Szabó; B J Day; A L Salzman
Journal:  FEBS Lett       Date:  1996-02-26       Impact factor: 4.124

9.  Modulation of vasoconstriction by insulin.

Authors:  S van Veen; P C Chang
Journal:  J Hypertens       Date:  1998-08       Impact factor: 4.844

10.  Sepiapterin decreases vasorelaxation in nitric oxide synthase inhibition-induced hypertension.

Authors:  Brett M Mitchell; Anne M Dorrance; Adviye Ergul; R Clinton Webb
Journal:  J Cardiovasc Pharmacol       Date:  2004-01       Impact factor: 3.105

View more
  26 in total

1.  Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells.

Authors:  Mohamed I Saad; Taha M Abdelkhalek; Moustafa M Saleh; Maher A Kamel; Mina Youssef; Shady H Tawfik; Helena Dominguez
Journal:  Endocrine       Date:  2015-08-14       Impact factor: 3.633

Review 2.  Insulin resistance in ischemic stroke.

Authors:  Xiao-Ling Deng; Zhou Liu; Chuanling Wang; Yanfeng Li; Zhiyou Cai
Journal:  Metab Brain Dis       Date:  2017-06-21       Impact factor: 3.584

3.  Linagliptin treatment improves cerebrovascular function and remodeling and restores reduced cerebral perfusion in Type 2 diabetes.

Authors:  Trevor Hardigan; Abdul Yasir; Mohammed Abdelsaid; Maha Coucha; Sally El-Shaffey; Weiguo Li; Maribeth H Johnson; Adviye Ergul
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-06-29       Impact factor: 3.619

4.  A chronic physical activity treatment in obese rats normalizes the contributions of ET-1 and NO to insulin-mediated posterior cerebral artery vasodilation.

Authors:  T Dylan Olver; Matthew W McDonald; Diana Klakotskaia; Rachel A Richardson; Jeffrey L Jasperse; C W James Melling; Todd R Schachtman; Hsiao T Yang; Craig A Emter; M Harold Laughlin
Journal:  J Appl Physiol (1985)       Date:  2017-02-09

Review 5.  Exercise and Vascular Insulin Sensitivity in the Skeletal Muscle and Brain.

Authors:  T Dylan Olver; M Harold Laughlin; Jaume Padilla
Journal:  Exerc Sport Sci Rev       Date:  2019-04       Impact factor: 6.230

Review 6.  The effects of obesity on the cerebral vasculature.

Authors:  Anne M Dorrance; Nusrat Matin; Paulo W Pires
Journal:  Curr Vasc Pharmacol       Date:  2014-05       Impact factor: 2.719

Review 7.  Common mechanisms of Alzheimer's disease and ischemic stroke: the role of protein kinase C in the progression of age-related neurodegeneration.

Authors:  Brandon P Lucke-Wold; Ryan C Turner; Aric F Logsdon; James W Simpkins; Daniel L Alkon; Kelly E Smith; Yi-Wen Chen; Zhenjun Tan; Jason D Huber; Charles L Rosen
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  Distinct temporal phases of microvascular rarefaction in skeletal muscle of obese Zucker rats.

Authors:  Jefferson C Frisbee; Adam G Goodwill; Stephanie J Frisbee; Joshua T Butcher; Robert W Brock; I Mark Olfert; Evan R DeVallance; Paul D Chantler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-10-10       Impact factor: 4.733

9.  Insulin resistance is associated with lower arterial blood flow and reduced cortical perfusion in cognitively asymptomatic middle-aged adults.

Authors:  Siobhan M Hoscheidt; J Mikhail Kellawan; Sara E Berman; Leonardo A Rivera-Rivera; Rachel A Krause; Jennifer M Oh; Michal S Beeri; Howard A Rowley; Oliver Wieben; Cynthia M Carlsson; Sanjay Asthana; Sterling C Johnson; William G Schrage; Barbara B Bendlin
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

10.  Prevention of hyperglycemic signal pathways in metabolic syndrome carotid artery of rats.

Authors:  Hiromi Kawai; Fengfeng Tian; Tomoko Kurata; Kentaro Deguchi; Toru Yamashita; Yoshio Omote; Syoichiro Kono; Koji Abe
Journal:  Transl Stroke Res       Date:  2012-08-14       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.